Mel Gibson's recent comments on a podcast have sparked a heated debate in the scientific community, highlighting the power of celebrity influence and the potential dangers of pseudoscience. The actor-director claimed that three friends with Stage 4 cancer were cured after taking an off-label combination of ivermectin and fenbendazole, an antiparasitic and veterinary dewormer, respectively. This claim has led to a dramatic surge in prescriptions for these drugs, particularly among young men, white patients, and those in the South. However, experts caution that there is little clinical evidence to support the use of these drugs for cancer treatment.
The UCLA-led study, which was not involved in the study, found that the number of prescriptions for the combination of ivermectin and fenbendazole jumped significantly in the months following Gibson's remarks. This increase was most pronounced among young men, white patients, and those in the South. The study's authors stressed that the findings do not prove that the podcast directly caused the spike in prescriptions, but they do raise concerns about the potential harm caused by following unproven advice.
Dr. Skyler B. Johnson of the University of Utah Huntsman Cancer Institute, who was not involved in the study, expressed concern about the potential for ivermectin to interfere with how the body processes cancer treatments and other medications. He also noted that the doses required for even a modest effect of ivermectin and fenbendazole would typically be considered toxic in humans. To date, no human clinical trials have shown that ivermectin and fenbendazole are safe or effective for treating cancer.
The study's authors, Dr. John N. Mafi and Dr. Katherine Kahn, stressed that not all widely shared health information is accurate, even when it comes from familiar or influential sources. They warned that using unproven treatments can carry real risks, especially if it delays care that is known to work. The researchers also noted that it remains unclear whether patients were taking the drugs alongside standard cancer treatments or instead of therapies such as chemotherapy or radiation.
The National Cancer Institute has announced that it is studying ivermectin's possible anti-cancer properties, but the research remains in the preclinical stage. This means that any findings are still far from being ready for actual patients. The study raises major questions that researchers say should be explored in the future, including whether patients are replacing proven cancer therapies with the drug combo, whether the treatments are causing harm, and which doctors are prescribing them.
In conclusion, Mel Gibson's comments have highlighted the potential dangers of celebrity influence and the need for caution when it comes to unproven health advice. The study's findings underscore the importance of relying on evidence-based medicine and the need for further research into the potential risks and benefits of off-label drug use.
